Abstract
Lineage trees have frequently been drawn to illustrate diversification, via somatic hypermutation (SHM), of immunoglobulin variable-region (IGV) genes. In order to extract more information from IGV sequences, we developed a novel mathematical method for analyzing the graphical properties of IgV gene lineage trees, allowing quantification of the differences between the dynamics of SHM and antigen-driven selection in different lymphoid tissues, species, and disease situations. Here, we investigated trees generated from published IGV sequence data from B cell clones participating in autoimmune responses in patients with Myasthenia Gravis (MG), Rheumatoid Arthritis (RA), and Sjögren's Syndrome (SS). At present, as no standards exist for cell sampling and sequence extraction methods, data obtained by different research groups from two studies of the same disease often vary considerably. Nevertheless, based on comparisons of data groups within individual studies, we show here that lineage trees from different individual patients are often similar and can be grouped together, as can trees from two different tissues in the same patient, and even from IgG- and IgA-expressing B cell clones. Additionally, lineage trees from most studies reflect the chronic character of autoimmune diseases.
| Original language | English |
|---|---|
| Pages (from-to) | 242-251 |
| Number of pages | 10 |
| Journal | Autoimmunity Reviews |
| Volume | 5 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2006 |
Bibliographical note
Funding Information:The work was supported in parts by grants from the Israel Science Foundation (grant number 759/01-1) and the Israel Cancer Research Fund (to RM) the BBSRC (to DDW) The Mayo Clinic Hematologic Malignancies Research Program (RSA) RM is also supported by grants from the Human Frontiers Science Program and the Swedish Foundation for Strategic Research (funding the Strategic Research Center for studies on Integrative Recognition in the Immune System, IRIS, Karolinska Institute, Stockholm, Sweden, where RM was on sabbatical during the writing of this article). DIS's research was supported by grants from The Wellcome Trust (054449/Z/98/Z), the European Commission (ERB 4001 GT 950115) and the Chief Scientist Office (K/MRS/50/c2738).
Funding
The work was supported in parts by grants from the Israel Science Foundation (grant number 759/01-1) and the Israel Cancer Research Fund (to RM) the BBSRC (to DDW) The Mayo Clinic Hematologic Malignancies Research Program (RSA) RM is also supported by grants from the Human Frontiers Science Program and the Swedish Foundation for Strategic Research (funding the Strategic Research Center for studies on Integrative Recognition in the Immune System, IRIS, Karolinska Institute, Stockholm, Sweden, where RM was on sabbatical during the writing of this article). DIS's research was supported by grants from The Wellcome Trust (054449/Z/98/Z), the European Commission (ERB 4001 GT 950115) and the Chief Scientist Office (K/MRS/50/c2738).
| Funders | Funder number |
|---|---|
| Mayo Clinic | |
| Israel Cancer Research Fund | |
| Wellcome Trust | 054449/Z/98/Z |
| Center for Strategic Research | |
| Medical Research Council | G0000160 |
| Biotechnology and Biological Sciences Research Council | |
| Chief Scientist Office | K/MRS/50/c2738 |
| European Commission | ERB 4001 GT 950115 |
| Human Frontier Science Program | |
| Stiftelsen för Strategisk Forskning | |
| Israel Science Foundation | 759/01-1 |
| Karolinska Institutet |
Keywords
- Autoimmune disease
- B lymphocyte
- Bioinformatics
- Lineage tree
- Somatic hypermutation